Personalized Stem Cells - FDA Approved Clinical Trials
  • Home
  • Patient
    • FAQ
  • Physician
  • Clinical Trials
    • Knee Osteoarthritis (fully enrolled)
    • COVID-19 Clinical Trials
    • Future Clinical Trials
  • About
    • Personalized Stem Cells
    • Leadership
    • Investors
  • Media
    • News
    • Blog
    • Videos
    • Facebook
  • Contact
  • 833-772-3557
Select Page
How a Stem Cell COVID-19 Clinical Trial Benefited Elephants

How a Stem Cell COVID-19 Clinical Trial Benefited Elephants

by Ashley | Mar 18, 2022 | Blog, COVID-19, Stem Cell

Yes, you read that title right. Stem cell therapy for COVID-19 is helping elephants! As you may know, Personalized Stem Cells developed and received FDA approval for a COVID-19 stem cell clinical trial in 2020. We later went on to license that trial to an outside...
Brazilian Phase 2 COVID-19 Stem Cell Clinical Trial Update

Brazilian Phase 2 COVID-19 Stem Cell Clinical Trial Update

by Ashley | Oct 1, 2021 | Blog, Clinical Trial, COVID-19, Stem Cell Therapy

For those who follow our blog, you are probably aware that Personalized Stem Cells (PSC) developed and received FDA approval for a COVID-19 stem cell clinical trial in 2020. We then went on to out-license this clinical trial, along with our allogeneic stem cell...
Brazilian Approval for COVID-19 Phase 2 Clinical Trial

Brazilian Approval for COVID-19 Phase 2 Clinical Trial

by Ashley | Jun 11, 2021 | Blog, Clinical Trial, COVID-19

Lately, it seems, we are sharing updates regarding the COVID-19 cell therapy product and clinical trial every other week. The developments seem to be coming at a breakneck speed, as is warranted when faced with a crisis like the COVID-19 pandemic. Our latest news...

Personalized Stem Cells Announces Brazilian Approval for COVID-19 Clinical Trial Licensed to Sorrento Therapeutics

by Ashley | Jun 1, 2021 | Clinical Trial, COVID-19, Press Release, Stem Cell

Personalized Stem Cells, Inc (PSC), an adipose-derived stem cell company, announces the Brazilian Health Regulatory Agency (Anvisa) authorized a Phase 2 COVID-19 stem cell clinical trial. This approval comes shortly after the completion of a Phase 1b trial conducted...
Brazilian Phase 2 COVID-19 Stem Cell Clinical Trial Update

Enrollment Complete for COVID-19 Stem Cell Clinical Trial

by Ashley | May 14, 2021 | Blog, COVID-19, Stem Cell

In our most recent blog, we shared an update regarding the COVID-19 stem cell clinical trial that Personalized Stem Cells developed and secured FDA approval for. The trial, which we licensed to Sorrento Therapeutics, is studying the effects of allogeneic (donor...
« Older Entries
Copyright © 2023. Personalized Stem Cells. All rights reserved. Privacy Policy
/* First CSS File */ var giftofspeed = document.createElement('link'); giftofspeed.rel = 'stylesheet'; giftofspeed.href = 'https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css'; giftofspeed.type = 'text/css'; var godefer = document.getElementsByTagName('link')[0]; godefer.parentNode.insertBefore(giftofspeed, godefer);